She took 2 low doses of Mounjaro for 2 weeks (assuming the starting dose of 2.5mg every week like every other person) before she died. It's obvious some people don't react well to some meds, hence why meds are started on low dose, monitored for efficacy and possible reaction, and increased as necessary.
Her death has nothing to do with the safety or not of Mounjaro (or private pharmacies or online pharmacies or HCP monitoring unless she didn't buy them from a legal and registered one, which hasn't been mentioned) anymore than someone who took another prescription meds which didn't agree with them died and suddenly there are safety warnings about that drug. Even if she was prescribed this by a physical GP, she'd likely have reacted the same way to the drug in 2 weeks of starting and she'd likely have the same outcome as the HCP or GP wouldn't have been literally monitoring her reaction at home everyday. The issue was her body's reaction to the drug and not the drug being fake or from a private pharmacy.
This isn't about "defensiveness" (🙄) like a pp claimed but questioning and commenting on the usefulness of this news and 'warning' as opposed to other drugs that's done the same. Granted, it's still relatively new in its use in the UK so any news about it will be plastered unlike all the other meds. At some point, the opposite will be the case like other meds.
People who use Mounjaro already know (and others who haven't should read) information about Mounjaro before they take it, like every other medicine. If it didn't work for you, it doesn't mean it's bad. It just means it didn't work for you, like every other meds.
Sad for the woman and her family.